ArticleExperimental and therapeutic medicine2019

A meta-analysis of the safety and efficacy of bosentan therapy combined with prostacyclin analogues or phosphodiesterase type-5 inhibitors for pulmonary arterial hypertension.

Zhan-Cui Dang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.